229 related articles for article (PubMed ID: 18369167)
1. Diabetes increases atrophy and vascular lesions on brain MRI in patients with symptomatic arterial disease.
Tiehuis AM; van der Graaf Y; Visseren FL; Vincken KL; Biessels GJ; Appelman AP; Kappelle LJ; Mali WP;
Stroke; 2008 May; 39(5):1600-3. PubMed ID: 18369167
[TBL] [Abstract][Full Text] [Related]
2. Cognitive dysfunction and its clinical and radiological determinants in patients with symptomatic arterial disease and diabetes.
Tiehuis AM; Mali WP; van Raamt AF; Visseren FL; Biessels GJ; van Zandvoort MJ; Kappelle LJ; van der Graaf Y;
J Neurol Sci; 2009 Aug; 283(1-2):170-4. PubMed ID: 19268970
[TBL] [Abstract][Full Text] [Related]
3. MRI confirms mild cognitive impairments prodromal for Alzheimer's, vascular and Parkinson-Lewy body dementias.
Meyer JS; Huang J; Chowdhury MH
J Neurol Sci; 2007 Jun; 257(1-2):97-104. PubMed ID: 17316690
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal changes in brain volumes and cerebrovascular lesions on MRI in patients with manifest arterial disease: the SMART-MR study.
van der Veen PH; Muller M; Vincken KL; Witkamp TD; Mali WP; van der Graaf Y; Geerlings MI;
J Neurol Sci; 2014 Feb; 337(1-2):112-8. PubMed ID: 24314719
[TBL] [Abstract][Full Text] [Related]
5. Brain atrophy and cognition: interaction with cerebrovascular pathology?
Muller M; Appelman AP; van der Graaf Y; Vincken KL; Mali WP; Geerlings MI
Neurobiol Aging; 2011 May; 32(5):885-93. PubMed ID: 19520460
[TBL] [Abstract][Full Text] [Related]
6. Peripheral and central neurologic complications in type 2 diabetes mellitus: no association in individual patients.
Manschot SM; Biessels GJ; Rutten GE; Kessels RP; Gispen WH; Kappelle LJ;
J Neurol Sci; 2008 Jan; 264(1-2):157-62. PubMed ID: 17850822
[TBL] [Abstract][Full Text] [Related]
7. Progression of cerebral white matter lesions -- clinical and radiological considerations.
Enzinger C; Fazekas F; Ropele S; Schmidt R
J Neurol Sci; 2007 Jun; 257(1-2):5-10. PubMed ID: 17321549
[TBL] [Abstract][Full Text] [Related]
8. Cerebral small-vessel disease and progression of brain atrophy: the SMART-MR study.
Kloppenborg RP; Nederkoorn PJ; Grool AM; Vincken KL; Mali WP; Vermeulen M; van der Graaf Y; Geerlings MI;
Neurology; 2012 Nov; 79(20):2029-36. PubMed ID: 23115210
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia.
Smith EE; Egorova S; Blacker D; Killiany RJ; Muzikansky A; Dickerson BC; Tanzi RE; Albert MS; Greenberg SM; Guttmann CR
Arch Neurol; 2008 Jan; 65(1):94-100. PubMed ID: 18195145
[TBL] [Abstract][Full Text] [Related]
10. Brain atrophy in type 2 diabetes: regional distribution and influence on cognition.
Moran C; Phan TG; Chen J; Blizzard L; Beare R; Venn A; Münch G; Wood AG; Forbes J; Greenaway TM; Pearson S; Srikanth V
Diabetes Care; 2013 Dec; 36(12):4036-42. PubMed ID: 23939539
[TBL] [Abstract][Full Text] [Related]
11. Vascular brain lesions, brain atrophy, and cognitive decline. The Second Manifestations of ARTerial disease--Magnetic Resonance (SMART-MR) study.
Kooistra M; Geerlings MI; van der Graaf Y; Mali WP; Vincken KL; Kappelle LJ; Muller M; Biessels GJ;
Neurobiol Aging; 2014 Jan; 35(1):35-41. PubMed ID: 23932882
[TBL] [Abstract][Full Text] [Related]
12. MRI biomarkers of vascular damage and atrophy predicting mortality in a memory clinic population.
Henneman WJ; Sluimer JD; Cordonnier C; Baak MM; Scheltens P; Barkhof F; van der Flier WM
Stroke; 2009 Feb; 40(2):492-8. PubMed ID: 19109551
[TBL] [Abstract][Full Text] [Related]
13. Diabetes mellitus and progression of vascular brain lesions and brain atrophy in patients with symptomatic atherosclerotic disease. The SMART-MR study.
Kooistra M; Geerlings MI; Mali WP; Vincken KL; van der Graaf Y; Biessels GJ;
J Neurol Sci; 2013 Sep; 332(1-2):69-74. PubMed ID: 23835088
[TBL] [Abstract][Full Text] [Related]
14. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study.
Gouw AA; van der Flier WM; Fazekas F; van Straaten EC; Pantoni L; Poggesi A; Inzitari D; Erkinjuntti T; Wahlund LO; Waldemar G; Schmidt R; Scheltens P; Barkhof F;
Stroke; 2008 May; 39(5):1414-20. PubMed ID: 18323505
[TBL] [Abstract][Full Text] [Related]
15. Vascular risk factors and cognitive decline among elderly male twins.
Gotkine M
Neurology; 2007 May; 68(21):1871; author reply 1871. PubMed ID: 17515556
[No Abstract] [Full Text] [Related]
16. Three-dimensional MRI analysis of individual volume of Lacunes in CADASIL.
Hervé D; Godin O; Dufouil C; Viswanathan A; Jouvent E; Pachaï C; Guichard JP; Bousser MG; Dichgans M; Chabriat H
Stroke; 2009 Jan; 40(1):124-8. PubMed ID: 18948610
[TBL] [Abstract][Full Text] [Related]
17. Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up.
van Elderen SG; de Roos A; de Craen AJ; Westendorp RG; Blauw GJ; Jukema JW; Bollen EL; Middelkoop HA; van Buchem MA; van der Grond J
Neurology; 2010 Sep; 75(11):997-1002. PubMed ID: 20837967
[TBL] [Abstract][Full Text] [Related]
18. Lacunar lesions are independently associated with disability and cognitive impairment in CADASIL.
Viswanathan A; Gschwendtner A; Guichard JP; Buffon F; Cumurciuc R; O'Sullivan M; Holtmannspötter M; Pachai C; Bousser MG; Dichgans M; Chabriat H
Neurology; 2007 Jul; 69(2):172-9. PubMed ID: 17620550
[TBL] [Abstract][Full Text] [Related]
19. Accelerated cognitive decline in patients with type 2 diabetes: MRI correlates and risk factors.
Reijmer YD; van den Berg E; de Bresser J; Kessels RP; Kappelle LJ; Algra A; Biessels GJ;
Diabetes Metab Res Rev; 2011 Feb; 27(2):195-202. PubMed ID: 21294241
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular risk factors and cerebral atrophy in a middle-aged cohort.
Knopman DS; Mosley TH; Catellier DJ; Sharrett AR;
Neurology; 2005 Sep; 65(6):876-81. PubMed ID: 16186527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
